CDMOs announced expansions, exhibitors showcased automated equipment, and supply chain strategy discussions were a focus at CPHI Milan 2026.
|Articles|March 22, 2005
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-03-01-2005
- Volume 17
- Issue 3
The Application of Cryogenics for Sustainable Solvent Recovery
Author(s)Jon Trembley
Emissions control has long been a primary concern for the pharmaceutical processing industry in Europe, which relies on the use of a number of organic solvents for the manufacture of pharmaceutical products...
Advertisement
Articles in this issue
over 21 years ago
Taming the Regulatory Beast: Regulation versus Functionalismover 21 years ago
Field-Flow Fractionation With Multiangle Light Scatteringover 21 years ago
Big Pharma Smells Parallel Trade Victoryover 21 years ago
Keeping Supply Chains Healthyover 21 years ago
Current Trends in Biomanufacturingover 21 years ago
The European Search for Researchover 21 years ago
European Biotech Second to USAdvertisement
Related to this article
Mitigating nitrosamine risk requires assessing each product individually and chasing zero nitrite in pharmaceutical excipients is often impractical and costly.
Clinical, manufacturing, safety, and commercial teams all lean on shared data. They need to agree on who publishes each data product, who can use it, and what evidence goes with it.
Continuous overall equipment effectiveness can be used to pinpoint hidden downtime and process bottlenecks in real time.
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
2
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
3
Improving Oral Peptide Delivery Through Structural Modifications
4
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
5